RCM
ORKA

RA Capital Management’s Oruka Therapeutics ORKA Stock Holding History

RA Capital Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148M Buy
+1,554,597
New +$104M 1.29% 23
2017
Q1 		– Sell
-1,075
Closed -$662K – 28
2016
Q4 		$662K Sell
1,075
-1,340
-55% -$713K 0.09% 27
2016
Q3 		$1.48M Sell
2,415
-190
-7% -$122K 0.15% 29
2016
Q2 		$1.63M Sell
2,605
-998
-28% -$739K 0.23% 31
2016
Q1 		$2.7M Hold
3,603
– – 0.35% 36
2015
Q4 		$3.62M Sell
3,603
-153
-4% -$173K 0.36% 34
2015
Q3 		$4.02M Hold
3,756
– – 0.58% 37
2015
Q2 		$6.53M Buy
+3,756
New +$4.94M 0.66% 34

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RA Capital Management's ORKA Position: Q2 2026 in Review

RA Capital Management opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 1,554,597 shares worth $148M. The stake represents 1.29% of the portfolio and ranks #23 among its holdings. This is a return to the name: RA Capital Management previously reported a position in ORKA as recently as Q4 2016.

RA Capital Management first reported a position in ORKA in Q2 2015 and has held it in 8 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • RA Capital Management held 1,554,597 shares of Oruka Therapeutics worth $148M as of Q2 2026.
  • Oruka Therapeutics was a new RA Capital Management position in Q2 2026.
  • Oruka Therapeutics made up 1.29% of RA Capital Management's portfolio in Q2 2026, its #23 holding.
  • RA Capital Management first reported a position in Oruka Therapeutics in Q2 2015 and has held it in 8 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on RA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.